Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eplerenone vs Ramipril for Endothelial Dysfunction in Obesity
NCT00608465Phase 4Terminated
- Sponsor
- Vanderbilt University
- Start
- May 2006
- Primary completion
- May 2009
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of eplerenone in metabolic syndrome, sponsored by Vanderbilt University. Started May 2006; status: terminated.
02
Drugs
eplerenone
03
Conditions
metabolic syndrome
Beyond the preview
Go deeper on NCT00608465.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00608465.